ALLERGY AND SECRETORY OTITIS MEDIA
DOI:
https://doi.org/10.5457/ams.v37i2.17Keywords:
allergies, scretory otitis mediaAbstract
Introduction: According to recent studies the role of allergy in ethipathogenesis of secretory otitis media is the leading one.The incidence of allergy in secretory otitis media varies from 57% to 100% according to recent studies.The allergic inflammation of the middle aer mucosa is of Th 2 type inflammation of respiratory mucosa.Increased number of activated mast cells, mastocyte tryptase, eosinophyllic cationic protein and mRNA for IL 5 were found in mucosa and effusion in SOM. The aim of this sudy was to investigate the presence of allergies in children with secertory otitis media and to follow up the outcome after antoallergic therapy. Patients and Methods: In this study 71 children with SOM entered the diagnostic procedure for allergy tests. Clinical examination by alergologist, skin prick test, sIgE, eosinophils in nasal lavage were performed.Allergy management was introduced in group of 38 (54%) children with diagnosis of allergy and secretory otitis media. Antihistamines, intranasal cortocosteroids, and elimination of identified antigen were the first line therapy . Results: After follow up period of three months in 21(47%) children out of 38 with allergy an secretory otitis the complete recovery of middle ear function was seen. After follow up period of 6 months in 27 (61%) children was noticed complete recovery and the rest of 17 children underwent surgical therapy. Discussion and Conclusion: Allergy screening is not conventional tool in diagnosis of secretorz otiti media. The results of this study as well as results of other clinicall studies implies to introduction allergzy tests in clonicall diagnostic procedure Antiallergic therapy can contribute to conservative management of disease and decrease the number of patient for surgical therapy.
Downloads
Issue
Section
License
Copyright transfer
The listed authors warrant that they are the authors and sole owners of the submitted manuscript. The authors also warrant that the work is original; that it has not been previously published in print or electronic format and is not under consideration by another publisher or electronic medium; that it has not been previously transferred, assigned, or otherwise encumbered; and that the authors have full power to grant such rights. With respect to the results of this work, the manuscript of this or substantially similar content will not be submitted to any other journal until the review process in the Acta Medica Salinianana has been officially completed (acceptance or rejection of the manuscript). The paper will not be withdrawn from the review process by the Acta Medica Saliniana Editorial Board until the review process is completed. The authors will comply with the requests of the Acta Medica Saliniana Editors and reviewers to improve the paper for publication. The eventual disagreements will be submitted in a written form; the authors are aware that the disagreement(s) with the Acta Medica Saliniana requests may result in the rejection of the manuscript. The authors hereby grant to the Acta Medica Saliniana the right to edit, revise, abridge, and condense the manuscript. If the manuscript is accepted for publication in the Acta Medica Saliniana, the authors hereby transfer the copyright of the paper to the Acta Medica Saliniana. The authors permit the Acta Medica Saliniana to allow third parties to copy any part of the journal without asking for permission, provided that the reference to the source is given. For papers with more than one author: All other co-authors agree to allow the corresponding author to make decisions regarding prepublication release of the information in the paper to the media, federal agencies, or both.
